370 related articles for article (PubMed ID: 12117355)
1. Mechanisms of action of the 5-HT1B/1D receptor agonists.
Tepper SJ; Rapoport AM; Sheftell FD
Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355
[TBL] [Abstract][Full Text] [Related]
2. Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
Deleu D; Hanssens Y
J Clin Pharmacol; 2000 Jul; 40(7):687-700. PubMed ID: 10883409
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
Goadsby PJ; Knight Y
Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological, pharmacokinetic and clinical profile of eletriptan (Relpax), a new triptan for migraine].
Omote M
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):93-101. PubMed ID: 12843576
[TBL] [Abstract][Full Text] [Related]
5. Targeting the 5-HT
Huang PC; Yang FC; Chang CM; Yang CP
Prog Brain Res; 2020; 255():99-121. PubMed ID: 33008517
[TBL] [Abstract][Full Text] [Related]
6. Is selective 5-HT
Rubio-Beltrán E; Labastida-Ramírez A; Villalón CM; MaassenVanDenBrink A
Pharmacol Ther; 2018 Jun; 186():88-97. PubMed ID: 29352859
[TBL] [Abstract][Full Text] [Related]
7. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Deleu D; Hanssens Y
Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
[TBL] [Abstract][Full Text] [Related]
8. Serotonin receptor ligands: treatments of acute migraine and cluster headache.
Goadsby PJ
Handb Exp Pharmacol; 2007; (177):129-43. PubMed ID: 17087122
[TBL] [Abstract][Full Text] [Related]
9. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
Kayser V; Aubel B; Hamon M; Bourgoin S
Br J Pharmacol; 2002 Dec; 137(8):1287-97. PubMed ID: 12466238
[TBL] [Abstract][Full Text] [Related]
10. Acute treatment of migraine and the role of triptans.
Freitag FG
Curr Neurol Neurosci Rep; 2001 Mar; 1(2):125-32. PubMed ID: 11898508
[TBL] [Abstract][Full Text] [Related]
11. The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons.
Donaldson C; Boers PM; Hoskin KL; Zagami AS; Lambert GA
Neuropharmacology; 2002 Mar; 42(3):374-85. PubMed ID: 11897116
[TBL] [Abstract][Full Text] [Related]
12. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
Williamson DJ; Hill RG; Shepheard SL; Hargreaves RJ
Br J Pharmacol; 2001 Aug; 133(7):1029-34. PubMed ID: 11487512
[TBL] [Abstract][Full Text] [Related]
13. Triptans induce vasoconstriction of human arteries and veins from the thoracic wall.
Wackenfors A; Jarvius M; Ingemansson R; Edvinsson L; Malmsjö M
J Cardiovasc Pharmacol; 2005 May; 45(5):476-84. PubMed ID: 15821444
[TBL] [Abstract][Full Text] [Related]
14. Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity.
Willems E; De Vries P; Heiligers JP; Saxena PR
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):212-9. PubMed ID: 9750007
[TBL] [Abstract][Full Text] [Related]
15. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
Gupta P; Butler P; Shepperson NB; McHarg A
Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
[TBL] [Abstract][Full Text] [Related]
16. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.
Classey JD; Bartsch T; Goadsby PJ
Brain Res; 2010 Nov; 1361():76-85. PubMed ID: 20833155
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of 5HT in migraine.
Buzzi MG
Cephalalgia; 1999 Sep; 19(7):625-6. PubMed ID: 10524654
[No Abstract] [Full Text] [Related]
18. Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future.
Mitsikostas DD; Tfelt-Hansen P
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):241-9. PubMed ID: 22934751
[TBL] [Abstract][Full Text] [Related]
19. Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches.
de Hoon JN; Willigers JM; Troost J; Struijker-Boudier HA; Van Bortel LM
Clin Pharmacol Ther; 2000 Oct; 68(4):418-26. PubMed ID: 11061582
[TBL] [Abstract][Full Text] [Related]
20. Review of zolmitriptan and its clinical applications in migraine.
Dowson AJ; Charlesworth B
Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
